Adenuric

DRUG2 trials

Sponsors

Pharmtechnology LLC, University Hospital, Rouen

Conditions

BioequivalenceGout

Phase 1

Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

CompletedNCT03918551

Pharmtechnology LLCBioequivalence

Start: 2019-05-03End: 2019-06-06Updated: 2019-07-08

Phase 3

Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration

RecruitingNCT05109936

University Hospital, RouenGout

Start: 2023-08-02End: 2027-01-01Target: 128Updated: 2026-06-08